Industry News
New FDA Approved Drugs in Q1 2022
With the first three months of 2022 now in the rear-view mirror, the FDA has approved 10 new drugs (Table 1).
Ensitrelvir, A Novel Antiviral Drug Again…
In addition to vaccines, oral antiviral drugs are expected to play an important role in the treatment of COVID-19 caused by severe acute respiratory disease coronavirus-2 (SARS-CoV-2) infecti…
Challenges of Immunotherapy For Prostate …
On March 15, 2022, Merck announced that it would discontinue the KEYLYNK-010 study. Results of interim analysis showed that KEYTRUDA (pembrolizumab) in combination with LYNPARZA (olaparib) fa…
Immunotherapy + mRNA Technology To Treat …
The study found that cancer stem cells in triple-negative breast tumors had low expression of ligand-dependent corepressor (LCOR), which led to their escape from immunotherapy. On this basis,…
COVID-19 Drugs: Small Molecules VS. Antib…
Eleven COVID-19 therapeutic drug therapies are currently available globally, including eight injectable drug therapies and three oral drugs,
Paxlovid and Molnupiravir: What Are The D…
What are the differences between the COVID-19 oral drugs - Paxlovid and Molnupiravir.
Top 10 Breakthrough Technologies in 2022,…
On February 23, MIT Technology Review, a world-renowned technology media, announced the "2022 10 Breakthrough Technologies", with 4 from biomedical field. They are not only based on…
Game Changer? Paxlovid, First Oral Antiv…
FDA granted EUA for Pfizers oral antiviral drug Paxlovid for the treatment of COVID-19, a SARS-CoV-2-3CL protease inhibitor.
Nanoparticles May Solve Thorny Problem In…
Patients need to receive regular hormone injections through syringes, insulin pumps or other devices. These treatments may be accompanied by life.
Development of Anti Influenza Drugs: Curr…
Each year, seasonal influenza pandemics can result in 3-5 million severe cases and 290,000-650,000 respiratory disease-related deaths worldwide. So far, there are five documented influenza pa…
sales@huatengusa.com
+86 0731 89916275